Multiple-sclerosis
Multiple-sclerosis
Latest Posts
-
Research Suggests COVID-19 May Trigger Multiple Sclerosis
A recent study published in Scientific Reports suggests that COVID-19 may trigger Multiple Sclerosis (MS) in susceptible individuals through a process known as “molecular mimicry.” The study conducted by scientists at the National Institute of Allergy and…
-
New approach to Multiple Sclerosis treatment using immunosuppression and stem cells shows promise
New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS). Five years after receiving the treatment, called high-dose…
-
Multiple Sclerosis medication alemtuzumab can trigger severe B cell mediated brain inflammation
The multiple sclerosis (MS) therapy alemtuzumab can trigger severe, unpredictable side effects. This was the finding by a team led by Prof Dr Aiden Haghikia and Prof Dr Ralf Gold from the Department of Neurology of the…
-
Multiple sclerosis pathogenesis: association between amount of leaked hemoglobin and severity of brain shrinkage
A leak of a protein called hemoglobin from damaged red blood cells may be associated with brain shrinkage in multiple sclerosis. This is the conclusion of a team from Imperial College London, whose early-stage findings suggest treatments…
-
Treating traumatic nerve injury with 4-aminopyridine
Researchers at the University of Rochester Medical Center believe they have identified a new means of enhancing the body’s ability to repair its own cells, which they hope will lead to better diagnosis and treatment of traumatic…
You must be logged in to post a comment.